Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker.
Indian J Ophthalmol
;
2007 May-Jun; 55(3): 230-2
Article
in English
| IMSEAR
| ID: sea-70748
ABSTRACT
The development of anti-tumor necrosis factor (TNF) therapies is a milestone in the therapy of rheumatic diseases. It is of concern whether all potential undesired complications of therapy have been evaluated within clinical trials which have led to treatment approval. Specialists prescribing TNF blockers should be aware of the unusual and severe complications that can occur. We describe a case of endogenous endophthalmitis in a rheumatoid patient on TNF alpha blocker.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Arthritis, Rheumatoid
/
Aged
/
Female
/
Humans
/
Eye Infections, Bacterial
/
Endophthalmitis
/
Ultrasonography
/
Tumor Necrosis Factor-alpha
/
Antirheumatic Agents
/
Diagnosis, Differential
Type of study:
Diagnostic study
Language:
English
Journal:
Indian J Ophthalmol
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS